Comment: PARP inhibitor olaparib plus bevacizumab in women with ovarian cancer ecancer 4:23 5 years ago 235 Далее Скачать
Dr. Hardesty on Bevacizumab/PARP Inhibitor Combination in Ovarian Cancer OncLive 1:40 6 years ago 270 Далее Скачать
The AVANOVA study: niraparib and bevacizumab for ovarian cancer VJOncology 3:11 5 years ago 256 Далее Скачать
Dr. Mirza on Efficacy of Niraparib/Bevacizumab Combo in Recurrent Ovarian Cancer OncLive 2:18 5 years ago 299 Далее Скачать
Case 3: Benefit of PARP Inhibitor Maintenance in Ovarian Cancer Targeted Oncology 6:52 4 years ago 161 Далее Скачать
PARP inhibitor olaparib added to bevacizumab benefits women with ovarian cancer with and without... ecancer 5:32 5 years ago 173 Далее Скачать
Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer Touch Medical Media 35:35 2 years ago 90 Далее Скачать
Dr. Herzog on the FDA Approval of Olaparib/Bevacizumab as Frontline Maintenance in Ovarian Cancer OncLive 3:13 4 years ago 915 Далее Скачать
What is Maintenance therapy with Lynparza plus Avastin ? | OncoPower OncoPower 3:10 3 years ago 1 203 Далее Скачать
